A carregar...
Does Variation in Either Age at Start of Therapy or Duration of Therapy Make Chemoprevention with Finasteride Cost-Effective?
BACKGROUND: Incremental cost-effectiveness ratios (ICER) of finasteride for prostate cancer prevention are consistent with estimates beyond $100,000 per quality-adjusted life-year (QALY). The majority of these analyses are based on chemoprevention starting in men aged 50–55yrs. We sought to evaluate...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3666586/ https://ncbi.nlm.nih.gov/pubmed/22777393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2012.26 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|